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Introduction
During its life of 120 days in the circulation, 
functionality of the red blood cell (RBC) is maintained 
and cell removal is postponed by disposal of modified 
haemoglobin and damaged membrane components 
through vesiculation. When vesiculation capacity has 
reached its limits, the ongoing mechanical, osmotic and 
oxidative stress induces recognition and removal of the 
old RBC by the immune system1-3. The same mechanisms 
that cause the decrease in deformability, adenosine 
triphosphate (ATP) production and maintenance of redox 
status, are also likely to be responsible for the generation 
of removal signals. This process revolves around band 3 
and its partners1,2. 
Although considerable progress has been made 
in the characterisation of RBCs of various ages by 
comparative proteomics and metabolomics, the 
molecular details of the ageing mechanism(s) remain 
elusive2,4-6. This is mainly due to the practical and 
ethical limitations of manipulating RBCs in healthy 
volunteers. Insights obtained from investigating patients 
Background. During its 120 days sojourn in the circulation, the red blood cell (RBC) remodels its 
membrane. Acetylcholinesterase (AChE) is a glycosylphosphatidylinositol (GPI)-linked enzyme that 
may serve as a marker for membrane processes occurring this ageing-associated remodelling process.
Materials and methods. Expression and enzymatic activity of AChE were determined on RBCs of 
various ages, as obtained by separation based on volume and density (ageing in vivo), and on RBCs of 
various times of storage in blood bank conditions (ageing in vitro), as well as on RBC-derived vesicles.
Results. During ageing in vivo, the enzymatic activity of AChE decreases, but not the AChE protein 
concentration. In contrast, neither AChE activity nor concentration show a consistent, significant 
decrease during ageing in vitro. CD59, another GPI-linked protein that protects against complement-
induced removal, also remains constant during storage. The cellular content of the integral membrane 
protein glycophorin A, however, decreases with storage time in the more dense RBC fractions. The 
latter are enriched in echinocytes and other misshapen cells during storage. 
Discussion. Our findings suggest that, during RBC ageing, GPI-linked proteins and integral 
membrane proteins are differentially sorted. Also, the vesicles that are generated in vitro show a fast 
and extensive loss of AChE activity, but not of AChE expression. Thus, AChE characteristics may 
constitute sensitive biomarkers of RBC ageing in vivo, and a source of information on the structural 
and functional changes that GPI-linked proteins undergo during ageing in vivo and in vitro. This 
information may help to understand RBC homeostasis and the effects of transfusion, especially in 
immunologically compromised patients.
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with RBC-centred pathologies are obscured by disease-
specific and systemic effects7,8. Thus, storage in blood 
bank conditions may be the most valid model for the 
elucidation of RBC ageing processes, with the highest 
translational value9-11.
In all conditions, the study of RBC ageing is 
hampered by the absence of an easily determined, 
unambiguous, general age marker. Acetylcholinesterase 
(AChE), linked to the RBC membrane through a 
glycosylphosphatidylinositol (GPI) anchor, might be 
such a marker for RBC ageing in vivo12. Determination 
of AChE characteristics may also yield information on 
the mechanism of ageing-associated vesicle formation. 
Microvesicles generated after an increase in intracellular 
calcium concentration or after mechanically-induced 
membrane deformation in vitro have been described 
to be enriched in AChE as well as other GPI-anchored 
proteins such as CD55 and CD59, with a concomitant 
depletion of these proteins in the cellular membrane13-15. 
In addition, we have found that the membrane 
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storage in blood bank conditions changes with storage 
time16. Therefore, we investigated the structural and 
functional changes that AChE undergoes during RBC 
ageing in vivo, and compared this with ageing in vitro 
during storage in blood bank conditions. 
Materials and methods
Red blood cell sampling
Fresh RBCs were isolated from 5 mL whole EDTA-
blood from healthy volunteers. Written informed consent 
was obtained from all donors. The study was performed 
following the guidelines of the local medical ethical 
committee and in accordance with the Declaration of 
Helsinki. Storage experiments were performed with 
RBCs from 5 leucodepleted red cell concentrates (3 blood 
group A RhD-positive donors, 1 blood group A RhD-
negative donor, 1 blood group O RhD-positive donor), 
as described before17. Samples of 10 mL were taken 
at 1, 7, 14, 21, 28 and 35 days after blood collection. 
RBCs were isolated from fresh blood and leukocytes 
and platelets were removed as described before17. RBCs 
were extensively washed three times with Ringer (125 
mM NaCl, 5 mM KCl, 1 mM MgSO
4
, 32 mM Hepes, 
5 mM glucose, 2.5 mM CaCl
2
, pH 7.4) by repeated 
centrifugation for 15 min at 700 g. 
Red blood cell fractionation
Red blood cells were fractionated according to 
cell volume followed by a fractionation according to 
cell density as described earlier18, and fractions were 
combined to achieve 5 fractions ranging in cell age 
from young to middle-aged to old cells, as determined 
by their HbA1c content3. 
Red blood cell fractionation according to density was 
performed using a discontinuous Percoll gradient consisting 
of six layers ranging from 0% Percoll (1.060 g/mL) to 
80% Percoll (1.096 g/mL) and the resulting layers were 
combined into top, middle and bottom layer fractions, 
basically as described before17,18. 
Acetylcholinesterase activity assay
Acetylcholinesterase activity of intact RBCs at a 
concentration of 2×106 cells/mL and RBC-derived 
vesicles was measured using a modified Ellman's method 
under V
max
 conditions, basically as described before12,15. 
The AChE activity of vesicles was measured using the 
supernatant obtained after centrifugation for 30 min 
at 2,880 g in the presence of the butyrylcholinesterase 
inhibitor tetraisopropyl pyrophosporamide (0.1 μM, 
Sigma Life Sciences, Zwijndrecht, The Netherlands). 
One arbitrary AChE enzyme unit was defined as an 
increase in absorbance at 412 nm of 0.005 per minute, 
determined from the slope of the initial part of the 
absorption vs the time curve that was obtained by linear 
regression analysis. 
Flow cytometry
The presence of AChE on RBCs was examined by flow 
cytometry using goat anti-AChE ab34533 (biotin, 1:25; 
Molecular Probes, ABCAM, Uithoorn, The Netherlands), 
detected by a rabbit anti-goat labeled with Alexa 488 
(1:200; Molecular Probes). RBCs were analysed with a 
flow cytometer (FACScan; Becton Dickinson, Franklin 
Lakes, NJ, USA) and its accompanying software 
(CELLQUEST, Becton Dickinson). The results are 
expressed as percentages of AChE-positive RBCs and/
or their mean fluorescence intensity (MFI). Vesicles were 
isolated and analysed by flow cytometry, as described 
previously19.
Microscopy
Cells were suspended in Ringer and RBC morphology 
was assessed by classifying the cells in normocytes, 
echinocytes, cells of indistinct morphology (misshapen 
cells), stomatocytes, macrocytes, spherocytes, ovalocytes 
and elliptocytes in random field pictures, using confocal 
laser microscopy, as described before20. At least 100 cells 
were analysed per sample.
Results
In order to investigate the structural and functional 
changes in acetylcholinesterase upon ageing in vivo 
and in vitro, we started by determining enzymatic 
activity. RBCs isolated from whole blood and separated 
according to cell age by a double separation method 
showed a decrease in activity with increasing cell age 
Table I - Red blood cell (RBC) acetylcholinesterase (AchE) activity during ageing in vivo.  
Double separation Density separation
Fraction AChE activity ±SD N MFI anti-AChE N Layer AChE activity ±SD N MFI anti-AChE ±SD N
Young 100 4 100 1 Top 100 4 100 3
Middle-aged 83.70±30.71 4 102.69 1 Middle 79.70±16.01 4 97.96±11.11 3
Old 68.73*±18.34 4 99.78 1 Bottom 61.23*± 8.53 4 111.6±4.2 3
Acetylcholinesterase activity was measured for RBCs separated according to cell age using double separation, and on RBCs separated according to density 
using Percoll gradients (see "Materials and methods"). Enzyme activity, expressed as arbitrary units, and protein content, expressed as mean fluorescence 
intensity (MFI), were determined using a spectrophotometric assay and flow cytometry, respectively (see "Materials and methods").*p<0.05, as determined 
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(Table I). Similar differences were observed when cells 
were separated based on differences in cell density only 
(Table I). This loss of activity could be due to a selective 
loss of AChE-containing membrane by vesiculation. 
Quantitation of AChE content by flow cytometry, 
however, showed no differences between the various 
cell fractions (Table I). These data indicate that RBC 
ageing in vivo is not accompanied by a selective loss 
of AChE protein, but by a decrease in enzyme activity. 
In contrast, during ageing in vitro, i.e. during storage 
as red cell concentrates in the blood bank, the mean 
AChE activity of RBCs did not undergo a statistically 
significant change with storage time (Figure 1A). 
However, there was considerable variation between the 
red cell concentrates (data not shown), probably due to 
biological, inter-individual variability in the response to 
the artificial storage conditions17, 21. Measurement of the 
AChE activities of RBCs in density-separated fractions 
did not show a consistent correlation between enzyme 
activity and density, although there was a significant 
decrease in the most dense cell layer after 21 days of 
storage, which was not observed at later time points 
(Figure 1B). These observations are in stark contrast to 
the differences between the activity of Percoll-separated 
RBCs of fresh samples, i.e. before they underwent the 
red cell concentrate production procedure. Already on the 
first day, the AChE activity of the least dense RBCs was 
significantly reduced compared with the activity of fresh 
RBCs (Figure 1C). In contrast to the RBCs, pronounced 
changes were observed in RBC-derived vesicles. During 
storage, the vesicle concentration increases from a 
vesicle/RBC ratio of 1.0 at days 7 and 14 to a vesicle/
Figure 1 - Red blood cell acetylcholinesterase (AchE) activity during storage in blood bank conditions.
 (A) Acetylcholinesterase activity of unseparated red blood cells (RBCs) during storage. (B) AChE activity of RBCs during 
storage after Percoll separation per layer. (C) Comparison of AChE activity of Percoll-separated fresh RBCs and RBCs after 
one day of blood bank storage. (D) AChE activity of RBC-derived vesicles expressed as arbitrary (arb.) unit/total vesicle 
protein during storage. RBCs and vesicles were isolated and their AChE activity was measured as described in Materials 
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RBC ratio of 1.5 at day 21, and a vesicle/RBC ratio of 
4.3 on day 35, as has been shown before16. The AChE 
activity of these vesicles, however, showed a strong, 
steady decrease during storage (Figure 1D). 
CD59, another GPI-linked protein showed no change 
in cell content with storage time, neither in the whole 
population nor in the various cell fractions (Figure 2A). 
Similar data were obtained with an anti-AChE antibody 
and comparable data have been obtained for ageing in 
vivo3. In addition to GPI-anchored proteins, we included 
the integral membrane protein CD235a (glycophorin 
A) in our analyses. Even though there were no storage-
associated changes in the total cell population, there 
was a decrease in glycophorin A content in the higher 
density RBCs of the middle and bottom Percoll layers 
starting after one week of storage (Figure 2B). These 
data indicate a selective disappearance of integral 
membrane proteins upon storage. 
Ageing in vivo as well as ageing in vitro have 
been described to be accompanied by changes in cell 
shape9,18. We performed a semi-quantitative analysis of 
RBC morphology during storage, both in unseparated 
samples and in the RBC fractions obtained after density 
separation. Our data confirm previous data, showing 
an overall decrease in the fraction of normocytes when 
storage time increases, with a concomitant increase in the 
numbers of echinocytes and otherwise misshapen cells 
(Figure 3). Morphological analysis of the various Percoll 
Figure 2 - Red blood cell (RBC) CD59 and glycophorin A content during storage in blood bank conditions. 
 (A) Mean fluorescence intensity (MFI) of CD59 and (B) CD235a (glycophorin A) of unseparated samples, and the 
top, middle and bottom layers after density separation during storage time. MFI values are expressed as percentage 
relative to the MFI of the RBCs on day 1, respectively of the RBCs in the top layers. *p<0.05, **p<0.01, ***p<0.001. 
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reported previously3, does not necessarily imply sustained 
protection against complement activation-associated 
opsonisation during ageing24. Thus, during ageing in vivo, 
CD59 may very well undergo conformational changes 
that decrease its capacity to shield the RBC from the 
complement system. This implication of our findings 
warrants further investigation of the role of complement 
in RBC removal in physiological conditions.
The conspicuous discrepancy between AChE protein 
content and enzymatic activity becomes even more 
pronounced in the vesicles that are produced with 
increasing storage time (Table I and Figure 1D). This 
apparent enrichment of inactivated AChE in vesicles 
confirms previous proteomic and immunological data 
showing a removal of damaged membrane components 
by vesiculation, both in vivo and in vitro3-5,25-27. Thus, 
vesicles in red cell concentrates may constitute a rich 
and relatively pure source of damaged AChE, which 
may facilitate a molecular identification of the processes 
that cause the underlying structural alterations during 
ageing in vivo and in vitro. Such an identification will 
help in understanding the unwanted side effects of 
transfusion, especially with regard to complement-
mediated haemolysis in susceptible patients.
The data obtained by determination of AChE 
expression and activity during RBC storage in blood 
bank conditions emphasise the differences between 
ageing in vivo and ageing in vitro. In general, neither 
AChE expression nor enzymatic activity decreased 
significantly with storage time (Figure 1A). This result is 
in agreement with previous data showing no significant 
or only small alterations in AChE activity after 
prolonged storage times28. Also, there were hardly any 
consistent differences between the RBCs of the different 
Percoll layers (Figure 1B). Many other observations 
show storage-associated changes in morphology (Figure 
39), metabolism and membrane protein composition5,12. 
Figure 3 - Red blood cell (RBC) morphology during storage in blood bank conditions.
 RBCs were classified as normocytes, echinocytes, unclassified misshapen cells, or "others" (ovalocytes, elliptocytes, 
stomatocytes). 
layers showed considerable variation, even within one red 
cell concentrate during storage (data not shown), but in 
general this change occurred in all layers (Figure 3A and 
B), and the most dense layers are enriched in echinocytes 
already after one day of storage (Figure 3A). We found 
no statistically significant correlations between cell 
morphology, AChE activity or AChE content. 
D iscussion  
Flow cytometry measurements of protein expression 
show no alterations in cellular AChE content with 
ageing in vivo (Table I). Together with previous data 
on other GPI-linked proteins such as CD55 and CD593, 
as confirmed here, these findings suggest that there is 
no specific loss of GPI-linked proteins from the RBCs 
by vesiculation in physiological circumstances. Thus, 
previous findings suggesting selective sorting of GPI-
linked proteins and microdomain-associated proteins 
during RBC vesiculation13-16,22 are likely to be related to 
the method that was employed to generate such vesicles 
in vitro16. This conclusion is supported by proteomic data 
that show selective membrane and cytoskeletal protein 
sorting during vesicle formation, but also indicate that 
different mechanisms underlie vesicle generation in vivo 
and in vitro5. In contrast, AChE enzyme activity clearly 
decreases with ageing in vivo. Such a decrease was 
already visible after Percoll separation only (Table I). 
Since this density-based separation generates fractions 
that are only moderately enriched with young but not 
with older cells20,23, this finding strongly suggests that 
the first and major loss of enzyme activity in vivo occurs 
relatively early in RBC life. Thus, AChE activity, but not 
AChE amount, constitutes a sensitive biomarker of RBC 
ageing in vivo. This apparent divergence between changes 
in expression and activity of one GPI-linked protein 
indicates that the absence of a clear ageing-associated 
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A large inter-individual variability, together with an 
altered osmotic behaviour in response to the storage 
medium16, are likely to obscure any ageing-related 
changes occurring in blood bank conditions. Data on 
phosphatidylserine exposure support these hypotheses, 
as does the absence of a decrease in cell volume during 
storage, in spite of the large increase in vesicles2,16,25,29. 
These phenomena also hamper the interpretation of the 
flow cytometry data on CD59 and glycophorin A content 
with storage (Figure 2). A comparison of the various 
density fractions, however, suggests that during storage 
integral and lipid-linked membrane proteins undergo 
different fates when the RBCs change from discocytes 
to echinocytes (Figures 2 and 3). Such fates are likely 
to be dependent on selective removal by vesiculation. 
The relatively large difference in AChE activity 
between fresh and 1-day old RBCs (Figure 1C) is 
likely to be caused by loss of AChE in vesicles that 
are generated during the mechanical stress that the 
RBCs undergo during the production of the red cell 
concentrates. The small, but significant increase in 
phosphatidylserine-exposing RBCs during blood bank 
processing and/or in the first week of storage supports 
this theory21.
Conclusions
The physiological role of RBC-bound AChE is 
not clear, but our findings may provide new tools 
for studying the putative role of acetylcholine on 
RBC physiology, and the impact of transfusion on 
acetylcholinesterase-mediated RBC homeostasis and 
survival, and on the circulation30-33.
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